AstraZeneca Research Facilities - Sodertalje, Sweden

Go to navigation
Go to content

AstraZeneca’s R&D organisation is headquartered in Södertälje, situated south-west of Stockholm, Sweden’s capital city. AstraZeneca Research Facilities - Sodertalje, Sweden

Research here is focused mainly in the neuroscience area – developing new products for pain control and for treating disorders of the central nervous system.

Over 1,600 people from all disciplines work in research and development at Södertälje, where we employ over 8,000 people in total.

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 03:08 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Did you know

Contact us

Email enquiry form

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.